Public-to-private transactions and carve-out deals within the private equity healthcare space tripled last year amid an increasingly challenging market landscape, according to a report by Institutional Investor. Citing a new study by Bain & Company, it noted inflation and uncertainty are now pushing PE firms to do all-equity and club
Abris Capital Partners, a Central European private equity investor, is to acquire Dentstore, a distributor of dental consumables and equipment in Central Europe. The acquisition is Abris’ third in the sector, following its investments in Dentotal in November 2019 and Dentatechnica in November 2021. The agreement is conditional upon securing
Cytovation AS, a clinical stage immune-oncology company has closed its Series A financing round, raising a total of NOK180 million (USD20 million). The Series A round was led by Sandwater, a Norwegian venture capital firm that invests in groundbreaking companies across a range of industries including life sciences, and Canica,
CVC Credit has co-arranged the unitranche debt facilities, featuring an ESG margin ratchet, to support Partners Group’s acquisition (on behalf of its clients) of Pharmathen, a European pharmaceutical company, which closed on 20 January 2022. CVC Credit will support the continuing growth strategy of the business through its European Direct
Pictet Alternative Advisors (PAA), the Pictet Group’s wholly owned alternative investment business, has announced the launch of a second thematic private equity strategy, exclusively focused on health investments. The strategy complements PAA’s existing thematic private equity franchise, initiated with the successful fundraising of its first fund dedicated to technology, which
Barings has served as sole arranger of secured credit facilities to support the buyout of Prodieco Advanced Engineering Solutions (Prodieco) by Agility’s.
A Place for Mom (APFM), a US marketplace for senior care services, has raised USD175 million in growth equity funding to fuel the next stage of the company’s growth and transformation. The funding round was led by New York-based global venture capital and private equity firm Insight Partners, with additional
Funds advised by Marathon Asset Management are to acquire Kaléo, a privately held pharmaceutical company based in Richmond, Virginia. The total base purchase price is approximately USD310 million in cash, less certain adjustments, and includes potential net revenue-based milestone payments of up to approximately USD70 million in cash for the
Prevail Partners, an affiliate of Prevail CInfoWorks, has led a USD10 million Series A funding round in PolyPhotonix Limited, a developer of a noninvasive treatment for diabetic retinopathy.
Biotech company ONI has closed a USD75 million Series B funding round led by RCH Venture Partners and Casdin Capital. Section 32, ARTIS Ventures, Vertical Venture Partners, Axon Ventures and private investors, including Paul Conley also participated, along with existing investors, including Oxford Science Enterprises, also participated in the round.
13 February, 2025 – 5:00 pm
06 November, 2025 – 8:30 am
13 February, 2025 – 8:30 am
09 October, 2024 – 8:30 am
